Bronte Capital Management Pty Ltd.

John Hempton

Last 4 years copying the filings

$100 would be $180

+80.4% across 17 filings, buying each one the day it became public. Best quarter +12%, worst -9.6%.

All time

+151% since Feb 2019

Fund size $931M today

Aug 2022 to Aug 2026, at least 81% of the book priced each quarter. Not audited fund performance. What this covers

Each quarter is priced from the date its SEC filing became public, not the quarter it describes, and weighted by position size. A 13F shows long US stock holdings only, so shorts, cash, options, and anything bought and sold between two filings are not in this line.

New Brown Forman position and exited Nektar Therapeutics in Q2 2026.

$931.1M in this filing57 positionstop 10 = 72%

Holdings are from Jun 30, 2026, not today. Filed Aug 5, 2026. Next filing due ~Nov 14, 2026 - a fund that has since had a bad quarter will not show it here until then.

Spot holdings56 positions - $888.3M

1GOOGLAlphabet Inc12.28%
$109.1M - 305K shares-76K
2REGNRegeneron Pharmaceuticals11.41%
$101.4M - 163K shares-10K
3IBKRInteractive Brokers Group8.66%
$76.9M - 884K shares-398K

#	Stock					At filing	Now	Market cap	P/E
1	GOOGLAlphabet Inc	12.28%	$109.1M	305K	-76K	$357.37	$345.90 -3.2%	$4.23T	17.4
2	REGNRegeneron Pharmaceuticals	11.41%	$101.4M	163K	-10K	$623.54	$803.48 +28.9%	$82.7B	19.9
3	IBKRInteractive Brokers Group	8.66%	$76.9M	884K	-398K	$87.04	$92.06 +5.8%	$156.9B	36.5

54 more on a paid plan

Free shows three. Paid plans unlock the full portfolio, every quarter, and what changed.

Unlock all 54 holdings

What is missing

This filing does not include cash, short positions, private investments, bonds, or many overseas holdings.